Create personalized user journeys with Omnichannel Marketing as a Service.
Empower your marketing operations with AI and Data.
Adopt a future-proof holistic approach to content strategy.
Leverage a suite of professional services for pharma and life sciences.
Develop and enable adaptable pharma and life sciences marketing content.
Enable format-free marketing with content management platform.
End-to-end platform for content validation and sales force readiness.
AI-powered congress engagement coordinator.
Discover our story, values, and how we're making a positive impact
Explore the heart of our organization and meet the visionary minds
Join the Viseven team and grow your career with us
The Viseven team is about respect, diversity, comfortable working conditions, and equal opportunities for everyone. We explore, evolve, and adapt – together.
Let’s connect at the Pharma 4.0: Digitalization and Transformation Conference The Viseven team will attend the Pharma 4.0: Digitalization and Transformation Conference. Anna Malivska, product manager and modular approach expert at Viseven, will be one of the conference presenters covering her topic: From Raw Data to Rich Content: Crafting compelling stories with data-driven approaches At […]
Overcome Channel Constraints in Your Content Strategy Creating, approving, and distributing campaigns is an art form that demands careful planning in various scenarios: Join us at the event, where we’ll share insights to help your content thrive across any channel, free from constraints and optimized for omnichannel success. Meet the Experts and See Real Case […]
Connect with us at 2nd Pharma Omnichannel HCP Engagement Conference The Viseven team will attend the 2nd Pharma Omnichannel HCP Engagement Conference, in Lisbon on May 23-24, 2024. Nataliya Andreychuk, co-founder and CEO of Viseven, will be among the conference speakers presenting her topic: “Exploring the Synergy Between High-Quality Content, Data, and AI in Omnichannel […]
Join Us in Unleashing Innovation at NEXT Pharma Summit 2024 The Viseven team is attending the NEXT Pharma Summit 2024 to exchange experience with the leaders of the pharma’s top companies like Bayer, Merck, Biogen, Teva, and more. The conference will take place on May 14-15 in Dubrovnik. These are busy weeks for our team […]
Let’s unlock innovation at Reuters Pharma 2024 The Viseven team is anticipating over 15 hours of networking with top pharma changemakers. Yes, we are referring to Reuters Pharma EU 2024! Join us to discover how to understand HCP preferences, excel in omnichannel marketing, and elevate customer experience. Nataliya Andreychuk, CEO at Viseven, Iryna Zayachuk, Account Manager, […]
Join us at CEBioForum The Viseven team is heading to Warsaw for the Central European BioForum conference, which has been going on for 20 years straight. You’ll have the opportunity to schedule meetings with members of the Viseven team, including Nataliya Andreychuk (CEO), Nataliia Kulyba (Regional Director), Maciej Nazdion (Account Executive), Oleksandra Zikh (Team Lead SDR EMEACIS), […]
Let’s network at REpharmaUSA Join the event that brings together over 100 speakers dedicated to timely delivering life-saving treatments to patients. Don’t miss out on the opportunity to network with the attendees from Viseven, including Oksana Matviienko, Regional Director, and Leonardo Sanchez, AE Lead, at booth number 302. We are eager to engage in discussions […]
“Are you unbiased?” It’s a fair question after reading a title like this. The honest answer is not completely. We built eWizard, an AI-powered content supply chain platform, so we naturally have firsthand experience with the challenges pharma teams face and the capabilities that help solve them. That said, this article is not intended to […]
A groundbreaking drug is ready to change lives, but regulatory hurdles, soaring R&D costs, and pricing pressures stand in the way of its success. For the pharmaceutical industry, this scenario is the reality of 2026. With a global talent shortage, aging populations driving up healthcare demands, and supply chains still recovering from recent and ongoing […]
For years, pharma influence was relatively easy to recognize. It lived in congress halls, advisory boards, journal publications, and the voices of respected clinical experts. If a physician, researcher, or professor shaped how others understood a therapy area, they were likely part of the KOL conversation. That model still matters. But it no longer covers […]
